Opportunity Information: Apply for RFA DP 14 002
Apply for RFA DP 14 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving Access to Eye Care among Persons at High Risk of Glaucoma" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Feb 4, 2014 and posted on Feb 4, 2014.
- Applicants must submit their applications by Apr 1, 2014 Key Dates Letter of Intent Due Date March 03, 2014, Application Due Date April 01, 2014, by 1159 PM U.S. Eastern Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $9,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,300,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Section III. Eligibility Information 1. Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) For Profit Organizations Small Businesses For Profit Organizations (Other than Small Businesses) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American tribal organizations (other than Federally recognized tribal governments) Faith based or Community based Organizations Regional Organizations Bona Fide Agents a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. 2. Foreign Organizations Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC discretionary grant opportunity (RFA DP 14 002, CFDA 93.283) focuses on reducing preventable vision loss by improving how glaucoma is detected, managed, and tracked in the United States, especially among groups that face higher risk and persistent access barriers. The funding is structured around two related components: one aimed at practical, community level implementation research to get more high risk people into appropriate eye care and keep them in follow-up, and another aimed at building the public health data infrastructure needed to monitor glaucoma and vision health trends and guide policy and programs.
Component A, Improving Glaucoma Detection and Management, supports implementation research that moves beyond clinical efficacy and looks at what actually works in real communities. The intent is to help applicants plan, develop, implement, and evaluate community based interventions that increase access to eye care services and improve utilization, with an emphasis on earlier detection of glaucoma and stronger follow-up after screening or diagnosis. The opportunity highlights high risk populations such as African Americans over age 40, Asians, older adults age 65 and above (with particular attention to Hispanics), individuals with a family history of glaucoma, and people with diabetes. In practice, this component is geared toward testing and refining strategies that address common real-world barriers like lack of awareness, cost, transportation, limited provider availability, cultural and language mismatches, and poor care coordination. The expectation is that projects will generate actionable evidence about which community outreach, referral, navigation, reminders, partnerships, and service delivery approaches measurably increase screening, confirmatory exams, treatment initiation, and ongoing monitoring.
Component B focuses on surveillance system development and is aimed at establishing a functional, comprehensive national glaucoma and vision health surveillance system. The core purpose here is to improve the country’s ability to measure and compare vision-related outcomes over time by harmonizing methods used in national and state level surveys. This includes aligning how surveys assess vision loss, how vision loss affects activity performance, and how people access eye care, so that data are more consistent, comparable, and useful. This component also emphasizes working in conjunction with other public health entities to promote implementation, and producing outputs that are usable by providers, policymakers, and other end users who need timely information to design or refine programs. The surveillance work is expected to have the capacity to evaluate innovative vision and eye health measures, consider what additional data elements should be included, and lay out a plan for integrating, implementing, and disseminating information broadly. A key theme is accessibility: the resulting system should be easy for decision makers and stakeholders to use to monitor the burden of glaucoma, track trends, examine risk factors for vision loss, and identify social, economic, racial, and ethnic disparities that contribute to unequal outcomes and unequal access to care. The surveillance system is also positioned as a tool for monitoring progress toward Healthy People 2020 vision objectives.
From an administrative standpoint, the opportunity was posted February 4, 2014, with key dates including a letter of intent deadline that was updated to March 3, 2014, and an application deadline updated to April 1, 2014 (11:59 PM Eastern Time). The CDC anticipated making about three awards, with an estimated total funding amount of $9.5 million and an award ceiling of $1.3 million; no cost sharing or matching was required. Eligible applicants included a wide range of U.S. based entities such as public and private institutions of higher education (including HBCUs, Hispanic serving institutions, tribally controlled colleges and universities, and Alaska Native/Native Hawaiian serving institutions), nonprofits, for-profit organizations (including small businesses), and various levels of government and related public entities. Foreign organizations and foreign components of U.S. organizations were not eligible. For questions or access issues related to the full announcement, the listed contact was the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700 or pgotim@cdc.gov.
Overall, the grant opportunity is designed to connect practice and policy: Component A generates field-tested approaches to improve glaucoma detection and continuity of care in high risk communities, while Component B strengthens the national data backbone needed to measure the problem, reveal disparities, and support evidence-based decisions about where and how to invest in public health interventions that improve access and utilization of eye care.
Frequently Asked Questions (FAQs)
1. What is this CDC grant opportunity about?
This CDC discretionary grant opportunity (RFA DP 14 002, CFDA 93.283) is focused on reducing preventable vision loss by improving how glaucoma is detected, managed, and tracked in the United States, especially for populations at higher risk and those facing persistent barriers to accessing eye care.
2. What are the main parts (components) of the funding opportunity?
The opportunity is organized into two related components:
- Component A: Improving Glaucoma Detection and Management - supports community-level implementation research to increase access to eye care, improve utilization, detect glaucoma earlier, and strengthen follow-up and ongoing monitoring.
- Component B: Surveillance System Development - supports building a more functional, comprehensive national glaucoma and vision health surveillance system by improving consistency and comparability of vision-related measures across surveys and promoting usable outputs for decision makers.
3. What is the goal of Component A (Improving Glaucoma Detection and Management)?
Component A supports implementation research that focuses on what works in real communities (not just what works in controlled clinical settings). Projects are expected to plan, develop, implement, and evaluate community-based interventions that increase access to eye care services, improve utilization, support earlier detection of glaucoma, and improve follow-up after screening or diagnosis.
4. What kinds of barriers is Component A meant to address?
Component A is geared toward strategies that address real-world barriers such as lack of awareness, cost, transportation challenges, limited provider availability, cultural and language mismatches, and poor care coordination. The expectation is that projects will generate actionable evidence about approaches that measurably improve screening, confirmatory exams, treatment initiation, and ongoing monitoring.
5. What populations are emphasized as high risk in this opportunity?
The opportunity highlights several groups with higher risk for glaucoma and/or persistent access barriers, including:
- African Americans over age 40
- Asians
- Older adults age 65 and above (with particular attention to Hispanics)
- Individuals with a family history of glaucoma
- People with diabetes
6. What outcomes or evidence is Component A expected to produce?
Component A is expected to produce practical, field-tested evidence about which community outreach, referral, navigation, reminder systems, partnerships, and service delivery approaches increase:
- Screening uptake
- Completion of confirmatory eye exams
- Treatment initiation after diagnosis
- Follow-up and ongoing monitoring over time
7. What is the goal of Component B (Surveillance System Development)?
Component B is intended to establish a functional, comprehensive national glaucoma and vision health surveillance system. The goal is to strengthen the country’s ability to measure and compare vision-related outcomes over time and to guide policy and program decisions using consistent, usable data.
8. What does "harmonizing methods" mean in Component B?
In this opportunity, harmonizing methods refers to aligning how national and state-level surveys measure and report key vision-related topics. This includes improving consistency in how surveys assess vision loss, how vision loss affects activity performance, and how people access eye care, so results can be compared more reliably across places and over time.
9. What kinds of outputs are expected from the surveillance system work?
Component B emphasizes producing outputs that can be used by providers, policymakers, and other end users who need timely information. The resulting system is intended to help stakeholders monitor glaucoma burden, track trends, examine risk factors for vision loss, and identify disparities that contribute to unequal outcomes and unequal access to care.
10. How does Component B address health disparities?
A key theme in Component B is accessibility and usability for decision makers. The surveillance system is positioned to help identify social, economic, racial, and ethnic disparities related to glaucoma and vision loss, supporting more targeted and evidence-based public health action.
11. Does Component B include evaluating new or innovative measures?
Yes. The surveillance work is expected to have the capacity to evaluate innovative vision and eye health measures, consider what additional data elements should be included, and develop a plan for integrating, implementing, and broadly disseminating the information.
12. How is this surveillance work connected to broader national goals?
The surveillance system is positioned as a tool to monitor progress toward Healthy People 2020 vision objectives by improving the ability to track and compare vision and eye health outcomes over time.
13. When was this grant opportunity posted?
The opportunity was posted on February 4, 2014.
14. What were the key deadlines for this opportunity?
Key dates included:
- Letter of Intent deadline (updated): March 3, 2014
- Application deadline (updated): April 1, 2014 (11:59 PM Eastern Time)
15. How many awards did CDC expect to make and how much funding was available?
CDC anticipated making about three awards. The estimated total funding amount was $9.5 million, and the award ceiling was $1.3 million.
16. Was cost sharing or matching required?
No cost sharing or matching was required for this opportunity.
17. Who was eligible to apply?
Eligible applicants included a broad range of U.S.-based entities, such as:
- Public and private institutions of higher education (including HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, and Alaska Native/Native Hawaiian-serving institutions)
- Nonprofit organizations
- For-profit organizations (including small businesses)
- Various levels of government and related public entities
18. Are foreign organizations or foreign components eligible?
No. Foreign organizations and foreign components of U.S. organizations were not eligible.
19. What is the overall strategy behind having two components?
The opportunity is designed to connect practice and policy. Component A is intended to generate community-tested approaches that improve glaucoma detection and continuity of care in high-risk communities. Component B is intended to strengthen the national data backbone needed to measure glaucoma and vision health trends, reveal disparities, and support evidence-based decisions about where and how to invest in public health interventions.
20. Who should be contacted with questions or access issues related to the full announcement?
Questions or access issues were directed to the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700 or by email at pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Emerging Infectious Disease Detection in the Veterinary Public Health Sector in India
Previous opportunity: BLM UT Youth Opportunities to work on Conservation Project throughout UT Public Lands
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DP 14 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DP 14 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Emerging Infectious Disease Detection in the Veterinary Public Health Sector in India Apply for RFA GH 14 004 Funding Number: RFA GH 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Comprehensive Care for Children Affected by HIV and AIDS (C3) Apply for RFA OAA 14 000005 Funding Number: RFA OAA 14 000005 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Pilot Clinical Trials (R01) Apply for PAR 14 089 Funding Number: PAR 14 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PROJECT SOAR DRAFT FOR COMMENTS Apply for RFA OAA GH DRAFT PS Funding Number: RFA OAA GH DRAFT PS Agency: Agency for International Development Category: Health Funding Amount: $70,000,000 |
| NIDCD Research on Hearing Health Care (R21) Apply for PA 14 090 Funding Number: PA 14 090 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCD Research on Hearing Health Care (R01) Apply for PA 14 091 Funding Number: PA 14 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Information Technology (HIT) Capacity Building for Monitoring and Improving Health Outcomes Along the HIV Care Continuum Technical Assistance Center Apply for HRSA 14 088 Funding Number: HRSA 14 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement for the Historically Black Colleges and Universities (HBCU) Center for Excellence in Behavioral Health (HBCU CFE) Apply for TI 14 006 Funding Number: TI 14 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| Emerging Pandemic Threats One Health Workforce Apply for RFI EPT 2 OHW Funding Number: RFI EPT 2 OHW Agency: Agency for International Development Category: Health Funding Amount: $50,000,000 |
| Longitudinal Study of a Population based Cohort of People with Lupus Apply for RFA DP 14 004 Funding Number: RFA DP 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Emerging Pandemic Threats Program PREDICT 2 Apply for RFI EPT 2 PREDICT 2 Funding Number: RFI EPT 2 PREDICT 2 Agency: Agency for International Development Category: Health Funding Amount: $100,000,000 |
| Emerging Pandemic Threats Program Prepare and Respond Apply for RFI EPT 2 PR Funding Number: RFI EPT 2 PR Agency: Agency for International Development Category: Health Funding Amount: $45,000,000 |
| Announcement of Availability of Funds for Teenage Pregnancy Prevention Research and Demonstration Programs (Tier 2) Community Collaborative Academy Apply for AH TP2 14 001 Funding Number: AH TP2 14 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $890,000 |
| Community Approaches to Reducing Sexually Transmitted Diseases (CARs) Apply for CDC RFA PS14 1406 Funding Number: CDC RFA PS14 1406 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the University of the West Indies to Deliver and Institutionalize Leadership and Management Training for Health Professionals in Eleven Caribbean Partnership Framework Countries, under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1408 Funding Number: CDC RFA GH14 1408 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Limited Competition Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01) Apply for RFA RM 14 002 Funding Number: RFA RM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| NEI Collaborative Clinical Vision Research Project Grant (U10) Apply for PAR 14 096 Funding Number: PAR 14 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Vision Research Resouce Center Grant (UG1) Apply for PAR 14 097 Funding Number: PAR 14 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Vision Research Chairmans Grant (UG1) Apply for PAR 14 098 Funding Number: PAR 14 098 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Vision Research Clinical Center Grant (UG1) Apply for PAR 14 099 Funding Number: PAR 14 099 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DP 14 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.